bioAffinity Technologies Inc
(NASDAQ:BIAF)
Precision Pathology Services sold assets to bioAffinity Technologies (BIAF) on Tuesday, September 19, 2023 for $3.5M paid in cash & stock
$1.03
-0.03[-2.83%]
Last update: 3:59PM (Delayed 15-Minutes)
Get Real Time Here
$1.12
0.0900[8.74%]
Open1.100Close1.030
Vol / Avg.24.658K / 10.897KMkt Cap9.631M
Day Range1.030 - 1.13052 Wk Range1.020 - 4.230

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%

bioAffinity Technologies Stock (NASDAQ:BIAF), Key Statistics

bioAffinity Technologies Stock (NASDAQ: BIAF) analysis, key statistics.

Valuation Measures
Enterprise Value
1.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
375.42
Price / Book (mrq)
1.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-152.65%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.87
Total Liabilities (Quarterly)
775.2K
Total Assets
8.9M
Total Liabilities
775.2K
Profitability
Net income Growth
- -
Gross Margin
93.75%
Net Margin
-8816.36%
EBIT Margin
-8786.23%
EBITDA Margin
-8677.04%
Operating Margin
-9009.78%